(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -357.74%-2.48M | 21.51%-1.58M | 95.53%-33.78K | 77.32%-2.78M | 116.42%527.6K | 83.78%-541.33K | 39.64%-2.01M | 68.11%-754.99K | -5.04%-12.25M | -0.01%-3.21M |
Net income from continuing operations | -216.80%-4.11M | -32.49%-1.99M | 151.44%839.83K | 43.49%-7.37M | 16.72%-2.94M | 66.88%-1.3M | 52.47%-1.5M | 33.16%-1.63M | -11.39%-13.04M | -31.24%-3.53M |
Operating gains losses | ---535.6K | ---791.83K | --17.01K | --156.46K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -18.43%12.24K | -44.06%12.25K | -45.65%12.24K | -31.05%70.52K | -50.79%11.09K | -43.53%15.01K | -17.63%21.89K | -15.24%22.53K | 197.34%102.27K | -14.80%22.53K |
Asset impairment expenditure | --0 | --0 | --1.19M | 927.46%2.63M | --2.63M | --0 | --0 | --0 | --255.5K | ---- |
Unrealized gains and losses of investment securities | --1.79M | ---641K | ---2.96M | ---555.88K | ---555.88K | --0 | --0 | --0 | --0 | ---- |
Remuneration paid in stock | -116.09%-26.51K | -94.90%10.67K | -108.26%-23.04K | -36.73%748.85K | -67.86%95.9K | -49.32%164.82K | -25.01%209.15K | -0.74%278.98K | -26.64%1.18M | -12.28%298.39K |
Other non cashItems | 3,173.75%342.79K | -598.38%-454.17K | 77.24%-25.77K | 89.23%-179.83K | 101.36%9.56K | 96.24%-11.15K | 70.14%-65.03K | 74.89%-113.2K | -17.08%-1.67M | -23.50%-703.88K |
Change In working capital | -92.70%42.77K | 435.50%2.27M | 31.63%907.48K | 87.33%1.73M | 152.79%1.13M | 12.46%586.28K | -156.49%-677.18K | 216.22%689.43K | 259.50%921.25K | 239.86%445.92K |
-Change in receivables | -808.80%-264.99K | -263.65%-156.29K | -70.26%165.52K | 360.01%598.89K | 78.42%-90.62K | 178.56%37.39K | 187.58%95.5K | 60.78%556.62K | 52.56%-230.34K | -37.67%-419.9K |
-Change in prepaid assets | -0.58%93.84K | -78.42%12.6K | -216.47%-19.5K | 33.82%348.94K | 341.49%179.4K | 5,046.56%94.39K | -69.78%58.4K | -88.04%16.74K | 148.77%260.75K | 76.76%-74.29K |
-Change in payables and accrued expense | -52.93%213.92K | 390.66%2.42M | 556.09%761.47K | -12.67%777.94K | 10.46%1.04M | -19.85%454.5K | -138.66%-831.09K | 143.29%116.06K | 101.30%890.84K | 207.40%940.11K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -357.74%-2.48M | 21.51%-1.58M | 95.53%-33.78K | 77.32%-2.78M | 116.42%527.6K | 83.78%-541.33K | 39.64%-2.01M | 68.11%-754.99K | -5.04%-12.25M | -0.01%-3.21M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 4,209.58%1.52M | 1,072.09%1.24M | 119.54%110.42K | -39.36%-1.42M | -88.64%-692.29K | -146.63%-37K | 79.90%-127.5K | -13,676.94%-565.13K | 38.49%-1.02M | -97.62%-367K |
Capital expenditure reported | -8.11%-40K | ---- | ---- | 13.21%-874.72K | ---145.09K | ---37K | ---- | ---- | ---1.01M | ---- |
Net PPE purchase and sale | ---- | ---- | 98.50%-8.5K | ---- | ---- | ---- | ---- | -5,551.30%-565.13K | ---- | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---547.21K | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment purchase and sale | --1.56M | --1.3M | --118.92K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Interest received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -135.88%-12.44K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 4,209.58%1.52M | 1,072.09%1.24M | 119.54%110.42K | -39.36%-1.42M | -88.64%-692.29K | -146.63%-37K | 79.90%-127.5K | -13,676.94%-565.13K | 38.49%-1.02M | -97.62%-367K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,008.91%568.64K | 401.26%470.49K | -100.38%-14.38K | -43.75%3.94M | 2,675.05%285.63K | -99.28%51.28K | -402.80%-156.17K | 3,434.31%3.76M | -61.58%7M | -100.24%-11.09K |
Net issuance payments of debt | -128.04%-14.38K | -1,426.36%-409.98K | 46.48%-14.38K | 335.90%283.18K | 1,163.38%285.63K | 265.08%51.28K | 13.52%-26.86K | 13.52%-26.86K | 6.70%-120.04K | 25.08%-26.86K |
Net common stock issuance | 14,999,900.00%600K | --890.8K | --0 | -45.52%4.08M | --0 | -100.00%4 | --0 | --4.08M | -60.83%7.49M | -100.00%1 |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -50.16%269K | 7,000,100.00%70K |
Net other financing activities | ---16.99K | ---- | ---- | 33.35%-425.46K | --0 | --0 | ---129.31K | -262.65%-296.15K | 51.35%-638.31K | 87.20%-54.23K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,008.91%568.64K | 401.26%470.49K | -100.38%-14.38K | -43.75%3.94M | 2,675.05%285.63K | -99.28%51.28K | -402.80%-156.17K | 3,434.31%3.76M | -61.58%7M | -100.24%-11.09K |
Net cash flow | ||||||||||
Beginning cash position | -34.25%405.83K | -90.61%273.42K | -55.29%211.16K | -92.99%472.27K | -97.78%90.22K | 137.78%617.27K | -31.58%2.91M | -92.99%472.27K | 267.85%6.74M | -27.39%4.06M |
Current changes in cash | 26.25%-388.69K | 105.77%132.41K | -97.45%62.26K | 95.83%-261.11K | 103.37%120.94K | -113.85%-527.05K | 42.59%-2.29M | 198.14%2.44M | -227.71%-6.27M | -414.83%-3.59M |
End cash Position | -80.99%17.15K | -34.25%405.83K | -90.61%273.42K | -55.29%211.16K | -55.29%211.16K | -97.78%90.22K | 137.78%617.27K | -31.58%2.91M | -92.99%472.27K | -92.99%472.27K |
Free cash from | -335.37%-2.52M | 23.57%-1.63M | 96.80%-42.28K | 72.44%-3.65M | 110.68%382.52K | 82.75%-578.33K | 45.83%-2.14M | 44.48%-1.32M | 0.73%-13.26M | -4.79%-3.58M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.